HIV Mutation Detail Information

> Y181C Search Result


Mutation Information
Mutation Site Y181C
Mutation Type Amino acid level
Gene/Protein/Region Type RT
Relevant Drug efavirenz (EFV);nevirapine (NPV);lamivudine (LAM);emtricitabine (FTC);stavudine (D4T);zidovudine (AZT);tenofovir (TDF);abacavir (ABC);didanosine (DDI);emtricitabine (FTC);entecavir (ETV)
Country Togo
Literature Information
PubMed PMID 21663632
Disease HIV infection/AIDS
Published Year 2011
Journal Journal of the International AIDS Society
Title High prevalence of HIV-1 drug resistance among patients on first-line antiretroviral treatment in Lomé, Togo.
Author Dagnra AY,Vidal N,Mensah A,Patassi A,Aho K,Salou M,Monleau M,Prince-David M,Singo A,Pitche P,Delaporte E,Peeters M
Evidence Importantly, eight patients were already predicted to be resistant to etravirine, the new NNRTI, either because they harboured the single Y181V mutation (n = 3) or due to the presence of both Y181C and H221Y mutations (n = 5).

Contents
Description
Mutation Information Note
  • Gene/Protein/Region Type: Virus Gene (e.g. LMP-1) or Virus Protein (e.g. Rep 68) or Virus Region (e.g. S, X)
Literature Information Note
  • Evidence: sentence contains this mutation information in the citation